Menu Search
Equities

Perspective Therapeutics Inc

AAJ0:BER

Perspective Therapeutics Inc

Actions
  • Price (EUR)11.80
  • Today's Change0.70 / 6.31%
  • Shares traded--
  • 1 Year change+350.38%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 12:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Perspective Therapeutics Inc's revenues fell -59.63% from 3.55m to 1.43m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 7.34m to a larger loss of 46.51m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-19.37%
Return on equity-21.80%
Return on investment-20.14%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Perspective Therapeutics Inc fell by 11.76m. However, Cash Flow from Investing totalled 24.37m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 36.91m for operations while cash generated from financing totalled 785.00k.
Cash flow per share-1.12
Price/Cash flow per share--
Book value per share5.06
Tangible book value per share3.96
More ▼

Balance sheet in USDView more

Perspective Therapeutics Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.50%.
Current ratio27.73
Quick ratio--
Total debt/total equity0.005
Total debt/total capital0.005
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.